drugset / Trial / NCT02153437

Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers

NCT02153437

Phase 1 Terminated 7 enrolled Bristol-Myers Squibb
RandomizedParallel-groupTriple-blindBasic science

Summary

To determine the effect of our compound (BMS-919373) on electrical activity of the heart using pacemakers.

Timeline

Start
2014-10-30
Primary completion
2016-10-20
Completion
2016-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-919373 Small molecule Oral
Comparator sotalol Small molecule Oral

Indications